RecruitingNCT06825247

Assessment of the Psychosocial Sexual Health Competencies of Young Adults Born in France (including Those Whose Parents Were Born Abroad), and Proposal of a Sexual Health Promotion Model Adapted to the Needs Identified.


Sponsor

Centre Hospitalier le Mans

Enrollment

1,500 participants

Start Date

Jun 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Every year, between 4,000 and 6,000 people discover their seropositivity to the human immunodeficiency virus (HIV). The dynamics of new discoveries vary according to sexual orientation and birthplace. MSM born in France show the sharpest improvement, while heterosexuals born in France show a more moderate decline, and intravenous drug users (IDUs) are still at a low ebb. There is little fine-grained data available on a national scale to explain these dynamics among people living with HIV (PLHIV). The acquisition of Psychosocial Competencies in sexual health is a prerequisite for good sexual health. It is important for all young people, and all the more so for young people from immigrant backgrounds, whom we hypothesize, despite the limited existing literature, to be more vulnerable due to the influence of their origins, their parents' culture or language barrier, or even religion. The primary research question: What psychosocial skills should be included in a sexual health education program for young people born in France (including those born to migrant parents), to enable them to enjoy good sexual health in adulthood?


Eligibility

Min Age: 18 YearsMax Age: 29 Years

Inclusion Criteria3

  • Aged from 18 to 29 years
  • Born in France or its territories,
  • Be able to read and write French.

Exclusion Criteria2

  • They are under guardianship,
  • They refuse to take part in the study.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centre Hospitalier Le Mans

Le Mans, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06825247


Related Trials